Tema Heart & Health ETF (NASDAQ:HRTS) Short Interest Update

by · The Cerbat Gem

Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totaling 1,595 shares, an increase of 151.2% from the April 15th total of 635 shares. Based on an average daily volume of 3,009 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.1% of the shares of the stock are sold short.

Tema Heart & Health ETF Stock Down 1.6%

HRTS traded down $0.55 on Friday, hitting $33.34. The company had a trading volume of 1,507 shares, compared to its average volume of 6,485. The business’s fifty day simple moving average is $33.72 and its 200 day simple moving average is $34.66. Tema Heart & Health ETF has a 12-month low of $26.78 and a 12-month high of $36.65. The company has a market cap of $49.68 million, a PE ratio of 22.06 and a beta of 0.70.

Institutional Investors Weigh In On Tema Heart & Health ETF

Several large investors have recently added to or reduced their stakes in HRTS. JPMorgan Chase & Co. bought a new stake in Tema Heart & Health ETF during the second quarter worth approximately $63,000. Jane Street Group LLC increased its stake in Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after acquiring an additional 3,202 shares during the last quarter. Citadel Advisors LLC bought a new position in Tema Heart & Health ETF during the third quarter valued at $243,000. CoreCap Advisors LLC increased its position in Tema Heart & Health ETF by 17.2% during the fourth quarter. CoreCap Advisors LLC now owns 60,679 shares of the company’s stock valued at $2,141,000 after acquiring an additional 8,903 shares during the last quarter. Finally, Brookstone Capital Management bought a new position in Tema Heart & Health ETF during the fourth quarter valued at $364,000.

Tema Heart & Health ETF Company Profile

(Get Free Report)

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Featured Stories